the prevalence of APOL1 high risk alleles in dialysis population in the Netherlands
- Conditions
- kidney disease
- Registration Number
- NL-OMON23827
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
all adults on dialysis with given informed consent
Exclusion Criteria
all patients who dit not give informed consent
Study & Design
- Study Type
- Not specified
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome is the prevalence of two high risks alleles of APOL1 gene in patients on dialysis in Dianet AMC and Utrecht, OLVG Oost and OLVG West. <br><br>
- Secondary Outcome Measures
Name Time Method The secondary outcome is prevalence of the two high risk alleles of APOL1 gene in patients on dialysis from Moroccan descent, from Africa, Suriname and the Netherlands Antilles descent and the prevalence of 1 or none high risk alleles of APOL1 gene.